Merrithew & Thorsten’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
Other funds holding LGND
Merrithew & Thorsten's LGND Position: Q3 2026 in Review
Merrithew & Thorsten sold out of Ligand Pharmaceuticals (LGND) in Q3 2026, closing a stake of 129 shares — an estimated $40K sold.
Merrithew & Thorsten first reported a position in LGND in Q4 2025 and held it in 3 quarters. The position peaked at $40K in Q2 2026. 348 funds tracked by Wall St. Rank hold LGND as of Q3 2026.
- Merrithew & Thorsten reported no remaining Ligand Pharmaceuticals position as of Q3 2026 after selling out during the quarter.
- Merrithew & Thorsten sold 129 Ligand Pharmaceuticals shares in Q3 2026, an estimated $40K.
- Merrithew & Thorsten first reported a position in Ligand Pharmaceuticals in Q4 2025 and held it in 3 quarters.
- Merrithew & Thorsten's Ligand Pharmaceuticals position peaked at $40K in Q2 2026.
- 348 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q3 2026.
Based on Merrithew & Thorsten's 13F filing for Q3 2026, filed 6 Nov 2026.